Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations

Medicine, Cancer Biology, Oncology +16

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

Medicine, Oncology, Pharmacology +12

The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway

Lynne Chantranupong, Sonia M. Scaria, Robert A. Saxton et al. · Cell · 2016 · 801 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient

Gregory A. Wyant, Monther Abu-Remaileh, Rachel L. Wolfson et al. · Cell · 2017 · 464 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14